WTC
MDGL icon

WhitTier Trust Company’s Madrigal Pharmaceuticals MDGL Stock Holding History

WhitTier Trust Company’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Hold
19
– – ﹤0.01% 1060
2026
Q1 		$10.1K Buy
19
+10
+111% +$4.78K ﹤0.01% 1041
2025
Q4 		$5.02K Hold
9
– – ﹤0.01% 1074
2025
Q3 		$3.99K Hold
9
– – ﹤0.01% 1098
2025
Q2 		$2.72K Hold
9
– – ﹤0.01% 1284
2025
Q1 		$2.98K Buy
9
+2
+29% +$657 ﹤0.01% 1236
2024
Q4 		$2.16K Hold
7
– – ﹤0.01% 1232
2024
Q3 		$1.49K Hold
7
– – ﹤0.01% 1248
2024
Q2 		$1.96K Buy
+7
New +$1.67K ﹤0.01% 1172

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WhitTier Trust Company's MDGL Position: Q2 2026 in Review

WhitTier Trust Company held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 19 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

WhitTier Trust Company first reported a position in MDGL in Q2 2024 and has held it in 9 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • WhitTier Trust Company held 19 shares of Madrigal Pharmaceuticals worth $10.4K as of Q2 2026.
  • WhitTier Trust Company left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1060 holding.
  • WhitTier Trust Company first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.